Fiji Kava Ltd

Fiji Kava bringing products 'from farm to shelf' backed by research and clinical trials

Fiji Kava Ltd (ASX:FIJ) chief executive Zane Yoshida introduces Proactive Investors to the newly-listed company, and explains the history behind as well as market opportunities for kava.

The company aims to bring a range of products "from farm to shelf," supported by strong research and development, and clinical trials with the National Institute of Complementary Medicine.

Taki Mai-branded products are already available for sale online, and Fiji Kava-branded products will be launched in the coming months, available through e-commerce giant Amazon.

Quick facts: Fiji Kava Ltd

Price: $0.08

Market: ASX
Market Cap: $5.23 m


e-Therapeutics’ Barlow hails deals with Novo Nordisk and ‘top five pharma...

Ray Barlow, chief executive of e-Therapeutics (LON:ETX), talks to Proactive’s Andrew Scott about the company’s unique approach to drug discovery, which uses computational techniques to find potential breakthrough new treatments. He also provided some insight into recent tie-ups with Denmark’s...

4 days, 2 hours ago

2 min read